COMMUNIQUÉS West-GlobeNewswire

EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus
04/06/2026
Steroid use reduction and disease control: In additional results from the Phase 3 PHOENYCS GO study, dapirolizumab pegol (DZP) plus standard of care was associated with sustained disease control at lower glucocorticoid [...]
ALK will present data on real world-use of nasal adrenaline and key learnings from 20 years with SLIT-tablets at EAACI 2026
04/06/2026
At the Annual Congress of the European Academy of Allergy and Clinical Immunology (EAACI) which will this year take part in Istanbul, Türkiye from 12 to 15 June 2026, the Danish pharmaceutical company ALK will present [...]
DaltonTx launches its drug discovery platform, Dalton, and announces Sygnature Discovery collaboration
04/06/2026
Dalton is a drug discovery platform integrating agentic AI, human expertise, and experimental data, into one continuous learning engine Announces collaboration with Sygnature Discovery, a leading integrated drug [...]
Valneva Announces Availability of Documentation for its Annual General Meeting
04/06/2026
Lyon (France), June 4, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company (“the Company”), today announced the availability of documentation for its Annual General Meeting (“the Meeting [...]
Jade Biosciences Announces Pricing of Public Offering of Common Stock
04/06/2026
SAN FRANCISCO and VANCOUVER, British Columbia, June 03, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade” or the “Company”) (Nasdaq: JBIO), a clinical-stage biotechnology company focused on developing best-in- [...]
Celcuity Inc. Announces Pricing of Upsized Public Offering of 0.250% Convertible Senior Notes Due 2032
04/06/2026
MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (“Celcuity” or the “Company”), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of [...]
POP Biotechnologies Secures Up to $9.7 Million in CEPI Funding
04/06/2026
Funding to Propel POP BIO SNAP™ Nanoparticle Vaccine Platform into Phase 1 Clinical Trials in the U.S. Buffalo, NY, June 03, 2026 (GLOBE NEWSWIRE) -- POP Biotechnologies, Inc. (“POP BIO”), a Buffalo-based biotechnology [...]
BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase
04/06/2026
LOUISVILLE, Ky., June 03, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services for complex [...]
Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year
03/06/2026
The company rises 196 spots to No. 791 on the Fortune 1000 2026 list following continued growth and momentum ORANGE, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) has been named to [...]
Jade Biosciences Announces Proposed Underwritten Public Offering
03/06/2026
SAN FRANCISCO and VANCOUVER, British Columbia, June 03, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade” or the “Company”) (Nasdaq: JBIO), a clinical-stage biotechnology company focused on developing best-in- [...]
ACTG Launches HIV Cure Study Evaluating Novel Approach Targeting the HIV Reservoir
04/06/2026
CHAPEL HILL, N.C., June 03, 2026 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the recent opening of study A5413, a study that expands upon the [...]
Iovance’s Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia
03/06/2026
First T cell therapy for a solid tumor cancer and first treatment option approved in Australia for advanced melanoma after anti-PD-1 and targeted therapy SAN CARLOS, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Iovance [...]
GLP North Adds Retaject Availability to Its Canadian Research Catalogue
03/06/2026
TORONTO, June 04, 2026 (GLOBE NEWSWIRE) -- GLP North, a Canadian supplier focused on ready-to-use research pen formats, has added Retaject availability to its Canadian research catalogue. The listing expands the company [...]
BrightSpring Announces Secondary Offering of Common Stock and Concurrent Share Repurchase
03/06/2026
LOUISVILLE, Ky., June 03, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services for complex [...]
Seer Files Definitive Proxy Materials and Mails Letter to Stockholders
04/06/2026
Reinforces Seer’s Clear Strategy, Strong Governance and Significant Long-Term Value Creation Opportunity Illustrates Why Radoff and Torok’s Short-Term Campaign Risks Disrupting Seer’s Momentum and Undermines Stockholder [...]
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 31, 2026
03/06/2026
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 31, 2026 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE [...]
Range Impact Announces $10 Million Investment from Tacora Capital
03/06/2026
CLEVELAND, OHIO, June 03, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact” or the “Company”), a public company dedicated to acquiring, reclaiming and repurposing distressed coal mine properties [...]
Booking Health Announces Release of Findings on International Access to Personalized Glioblastoma Treatment in Germany
03/06/2026
Langenfeld, Germany, June 03, 2026 (GLOBE NEWSWIRE) -- Booking Health today announced the release of findings examining international patient access to personalized dendritic cell therapy for glioblastoma in Germany. [...]
Celularity Releases CEO Letter to Shareholders
03/06/2026
FLORHAM PARK, N.J., June 03, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) ("Celularity" or the "Company"), a longevity-focused regenerative and cellular medicine company pioneering placental-derived cellular [...]

Pages